Tag: Gene Therapy

Aflibercept Won’t Help Vision in Early Diabetic Retinopathy

Intravitreal injections with aflibercept (Eylea) don’t improve the visual acuity of people with nonproliferative diabetic retinopathy (NPDR), researchers say. The treatments do reduce the risk for center-involved diabetic macular edema and proliferative diabetic retinopathy, however, said Adam R. Glassman, MS, principal investigator of the DRCR Retina Network Coordinating Center, Tampa, Florida. “Some clinicians may decide

Scientists launch clinical trial of CRISPR gene correction therapy in patients with sickle cell disease

Scientists at UC San Francisco, UC Berkeley and UCLA have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patient's own blood-forming stem cells. The trial will combine CRISPR technology developed at Innovative Genomics

Scientists develop technique to observe radiation damage over femtoseconds

Scientists at Nanyang Technological University, Singapore (NTU Singapore) have developed a technique to observe how radiation damages molecules over time-frames of just one quadrillionth of a second — or a femtosecond. The technique involves dissolving organic molecules in water to simulate the state molecules are found in biological tissue. This allows the research team to

How cortisol affects exposure therapy for anxiety disorders

Bochum-based psychologists have studied how the application of the stress hormone cortisol affects exposure therapy for anxiety disorders. The researchers knew from earlier studies that extinction learning, which constitutes the foundation of exposure therapy, can be reinforced by administering cortisol. However, the team headed by Professor Armin Zlomuzica at Zentrum für Psychotherapie (psychotherapy centre) at

‘Master pacemaker’ for biological clocks identified

What makes a biological clock tick? According to a new study from U of T Mississauga, the surprising answer lies with a gene typically associated with stem and cancer cells. In the first study of its kind for the field of circadian biology, UTM researchers used RNA sequencing to observe the expression of genes in

Visualizing better cancer treatment: Researchers engineer a protein micelle that can be visualized by MRI as it delivers hemotherapeutics

A team of researchers from New York University has engineered nanoscale protein micelles capable of both delivering chemotherapeutic drugs and of being tracked by magnetic resonance imaging (MRI). The innovation falls into the category of “theranostics,” meaning that it combines diagnostic capability and drug delivery, allowing researchers to administer therapy while also non-invasively monitoring the

Earlier emergence of malaria in Africa

Malaria, which claims hundreds of thousands of lives each year — mainly children and especially in Africa -, is one of the leading causes of death by an infectious agent, the Plasmodium falciparum parasite. In research on malaria, the genetic mutation that causes sickle cell anemia (also known as drepanocytosis), a chronic disease that is

New form of hereditary osteoporosis

A research group headed by Professor Outi Mäkitie, University of Helsinki, Finland, identified in families with childhood-onset osteoporosis disease-causing mutations in a gene that had previously not been connected with the skeletal system or osteoporosis. “Through extensive genetic research, we identified a gene defect underlying osteoporosis in two Finnish families with several affected family members.

CRISPR gene editing will find applications in plastic and reconstructive surgery

The CRISPR genome editing technique promises to be a “transformative leap” in genetic engineering and therapy, affecting almost every area of medicine. That includes plastic surgery, with potential advances ranging from prevention of craniofacial malformations, to therapeutic skin grafts, to new types of rejection-free transplants, according to a paper in the November issue of Plastic

Genetic disease healed using genome editing

Parents of newborns may be familiar with the metabolic disorder phenylketonuria: in Switzerland, all newborn babies are screened for this genetic disease. If a baby is found to have phenylketonuria, it needs a special diet so that the amino acid phenylalanine does not accumulate in the body. Excess phenylalanine delays mental and motor development. If

Decoding the regulation of cell survival: A major step towards preventing neurons from dying

An interdisciplinary and international research group led by Dr. Volker Busskamp from the Center for Regenerative Therapies Dresden at the TU Dresden (CRTD) has decoded the regulatory impact on neuronal survival of a small non-coding RNA molecule, so-called miRNA, at the highest resolution to date. This deciphering of gene regulation primes applications for strengthening neurons

Immediate compression could help prevent complications after deep-vein thrombosis: Study supports use of this simple, low-cost intervention even for patients without symptoms

People with deep-vein thrombosis (DVT) can substantially cut their risk of potentially debilitating complications by starting adequate compression therapy in the first twenty-four hours of DVT therapy (known as the acute phase of treatment), suggests a study published today in the journal Blood. DVT occurs when a blood clot forms in a deep vein, commonly

Lipid droplets play crucial roles beyond fat storage

Lipid droplets: they were long thought of merely as the formless blobs of fat out of which spare tires and muffin tops were made. But these days, they’re “a really hot area of research,” says Michael Welte, professor and chair of biology at the University of Rochester. That’s in part because lipid droplets have been